• article not found
  • Latest News from: UC Davis Health

    Filters close
    Released: 4-Mar-2024 6:05 PM EST
    Florette K. Gray Hazard appointed chair of Pathology and Laboratory Medicine
    UC Davis Health

    Florette K. Gray Hazard, a pediatric pathologist, has been appointed chair of the Department of Pathology and Laboratory Sciences at the UC Davis School of Medicine. She will lead a department with 50 faculty, 16 residents, and more than 400 academic and clinical staff.

    Released: 19-Dec-2023 2:05 PM EST
    Are over-the-counter eye drops safe?
    UC Davis Health

    Dozens of eye drop recalls this year have left consumers confused about product safety. An expert explains why there have been so many recalls and how to pick safe eye drops.

    Released: 18-Aug-2023 2:35 PM EDT
    Kids don't know they need glasses: 7 vision tips for parents
    UC Davis Health

    Can your child see the blackboard at school? Ophthalmologist Marcela Maria Estrada explains why kids often don’t know they have bad eyesight and gives tips for healthy vision.

    Newswise:Video Embedded anxiety-disorders-will-affect-nearly-1-in-3-adults-here-s-what-you-need-to-know
    VIDEO
    Released: 10-May-2023 6:20 PM EDT
    Anxiety disorders will affect nearly 1 in 3 adults: Here’s what you need to know
    UC Davis Health

    A UC Davis expert explains anxiety versus fear and how anxiety disorders can be effectively treated with therapy, medications and self-care.

    Released: 31-Jul-2018 6:05 PM EDT
    The Surge in Throat Cancer, Especially in Men
    UC Davis Health

    Humanpapilloma virus (HPV) is now the leading cause of certain types of throat cancer. Dr. Michael Moore, director of head and neck surgery at UC Davis and an HPV-related cancer expert, answers some tough questions about the trend and what can be done about it.

    Released: 3-Jan-2018 5:05 PM EST
    UC Davis Researcher Urges Caution on Engineered Stem Cells
    UC Davis Health

    In a commentary published in the Jan. 4 issue of the New England Journal of Medicine, UC Davis researcher William Murphy expressed cautious optimism about efforts to genetically engineer hematopoietic stem cells (HSCs) to temporarily resist cell death during transplantation. While these gene therapy approaches could dramatically improve patient outcomes, Murphy argues that their risks must be carefully studied in diverse models.


    Showing results 1 – 14 of 14


    close
    0.11597